Pulmonx Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Glendon E. French, with a market cap of $57.4M.
Common questions about Pulmonx Corporation
Pulmonx Corporation is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $20.3M.
Pulmonx Corporation has approximately 279 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.